Maile Parker, MD
Colon & Rectal Surgery · Springfield, ORNPI 1366880486
Payments from drug & device makers
What this record shows
The money is spread across several categories — education (55.8%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. Intuitive Surgical accounts for 94.3% of it on its own, with 11 other manufacturers making up the rest. Reporting peaked in 2019 at $3,102 and has fallen 88.1% since, to $368 in 2025.
Across 60 payments — averaging $119.54 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$7K
- Davol Inc.$150
- Boston Scientific$37
- Braintree Laboratories, Inc.$31
- Innovation Technologies Inc$30
- Smith+Nephew$27
- plus $133 from 6 others
What the payments were for
- Travel & lodging$1,05115%
- Food & beverage$2,11329%
- Education$4,00056%
- Gifts$90%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 44 | $6,764 |
| Davol Inc. | 4 | $150 |
| Boston Scientific | 2 | $37 |
| Braintree Laboratories, Inc. | 2 | $31 |
| Innovation Technologies Inc | 1 | $30 |
| Smith+Nephew | 1 | $27 |
| Baxter Healthcare | 1 | $26 |
| Solventum Corporation | 1 | $25 |
| Aimmune Therapeutics, Inc. | 1 | $24 |
| Heron Therapeutics, Inc. | 1 | $22 |
| Intercept Pharmaceuticals, Inc. | 1 | $21 |
| KCI USA, Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Da Vinci Surgical System$5,555
How this compares
$7,173 in reported general payments places this provider in the 65th percentile of 25 colon & rectal surgery providers in Oregon.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Sod Sulf-Potass Sulf-Mag SulfSodium, Potassium,mag Sulfates | 22 | $1,409 |
| Diphenoxylate-AtropineDiphenoxylate Hcl/Atropine | 20 | $584 |
| Peg-3350 And ElectrolytesPeg3350/Sod Sulf,bicarb,cl/Kcl | 29 | $435 |
| Gavilyte-GPeg3350/Sod Sulf,bicarb,cl/Kcl | 13 | $203 |
| Dicyclomine Hcl | 14 | $176 |
| Neomycin Sulfate | 30 | $166 |
| Oxycodone Hcl | 36 | $152 |
| Ondansetron OdtOndansetron | 66 | $135 |
| Metronidazole | 31 | $57 |
| Ondansetron Hcl | 26 | $44 |
Paid to pharmacies, not to this prescriber.
Other colon & rectal surgery in Springfield
- Duc VoSpringfield$8K
- Khayree ButlerPortland$93K
- Douglas KhouryPortland$49K
- Paul KaminskyPortland$42K
- Sungeyun ChoClackamas$31K
- Michael DoorlyHillsboro$16K
- Daniel HerzigPortland$8K
- Carey WickhamPortland$8K
- Phuong NguyenRedmond$7K
- Rodrigo Pedraza RosalesPortland$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.